Keene & Associates, Inc. Elanco Animal Health Inc Transaction History

Keene & Associates, Inc.

  • $130 Million
  • Q3 2024

A detailed history of Keene & Associates, Inc. transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Keene & Associates, Inc. holds 22,945 shares of ELAN stock, worth $269,144. This represents 0.26% of its overall portfolio holdings.

Number of Shares
22,945
Previous 21,705 5.71%
Holding current value
$269,144
Previous $313,000 7.35%
% of portfolio
0.26%
Previous 0.26%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024
BUY
$11.85 - $15.47 $14,694 - $19,182
1,240 Added 5.71%
22,945 $336,000
Q2 2024

Aug 09, 2024
SELL
$12.93 - $18.45 $27,282 - $38,929
-2,110 Reduced 8.86%
21,705 $313,000
Q1 2024

Apr 24, 2024
SELL
$14.37 - $16.46 $405,075 - $463,990
-28,189 Reduced 54.21%
23,815 $387,000
Q4 2023

Jan 29, 2024
SELL
$8.6 - $14.94 $774 - $1,344
-90 Reduced 0.17%
52,004 $774,000
Q3 2023

Oct 13, 2023
BUY
$9.81 - $12.62 $21,385 - $27,511
2,180 Added 4.37%
52,094 $585,000
Q2 2023

Jul 26, 2023
BUY
$8.08 - $10.37 $2,601 - $3,339
322 Added 0.65%
49,914 $502,000
Q1 2023

Apr 19, 2023
BUY
$8.79 - $14.58 $337,474 - $559,769
38,393 Added 342.83%
49,592 $466,000
Q4 2022

Feb 09, 2023
SELL
$11.49 - $13.65 $191,021 - $226,931
-16,625 Reduced 59.75%
11,199 $136,000
Q3 2022

Nov 01, 2022
BUY
$12.41 - $32.42 $27,984 - $73,107
2,255 Added 8.82%
27,824 $345,000
Q2 2022

Jul 21, 2022
BUY
$19.63 - $26.62 $30,014 - $40,701
1,529 Added 6.36%
25,569 $502,000
Q1 2022

Apr 12, 2022
BUY
$24.65 - $29.0 $83,686 - $98,455
3,395 Added 16.44%
24,040 $627,000
Q4 2021

Jan 31, 2022
BUY
$27.74 - $34.09 $572,692 - $703,788
20,645 New
20,645 $586,000

Others Institutions Holding ELAN

# of Institutions
438
Shares Held
473M
Call Options Held
4.62M
Put Options Held
753K
View Full List

About Elanco Animal Health Inc

ELAN Quotes by TradingView
  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $5.56B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Keene & Associates, Inc. Portfolio

Follow Keene & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keene & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Keene & Associates, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email